 Today, we issued a press release announcing our financial results for the second quarter and providing a corporate update. It was 4.7 million lower than in the first quarter of this year, primarily because in March, some patients refilled their prescriptions a few days earlier than usual, so as to have a small amount of extra medicine on hand to safeguard against pandemic-related delivery delays. 